In 2026, pretreatment pregnancy testing still must happen in a medical setting before a teen takes a first isotretinoin dose. Home tests can be used during and after treatment, but not to clear treatment to start. iPLEDGE is the FDA safety program for isotretinoin that keeps fetal-risk safeguards in place. For parents, that means planning two clinic visits before the prescription begins.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Official resources:
- Read the original research from NIH — Use this page to review the original research.
- Explore the official data from FDA — Use this primary source to review the underlying data.
Table of Contents
- The Two Tests Before the First Dose
- Does Your Teen Fall Under These Rules?
- What Changed in 2026?
- How Monthly Refills Stay on Track
- What to Ask at the Visit
The Two Tests Before the First Dose
FDA documents describe two pretreatment tests. The first is a screening test when the prescriber decides to prescribe isotretinoin. The second is a confirmatory negative test after 30 days of two birth-control methods or abstinence.
The confirmatory test is timed to the first five days of the menstrual cycle, just before therapy. That timing follows the 30-day period of contraception or abstinence. Parents can use that gap to plan rides, school absences, and lab visits.
- Complete screening pregnancy test in a medical setting.
- Use two accepted methods or abstinence for at least 30 days.
- Complete confirmatory test in a medical setting in the first five cycle days.
Does Your Teen Fall Under These Rules?
DailyMed isotretinoin labeling limits oral isotretinoin to severe recalcitrant nodular acne in non-pregnant patients age 12 and older. It covers teens with multiple 5-mm or larger inflammatory nodules that did not respond to standard care including antibiotics. If your teen meets that description and can become pregnant, pretreatment testing applies.
The FDA prescriber guide requires two simultaneous accepted birth-control methods or continuous abstinence. The requirement starts at least 30 days before treatment, continues during treatment, and lasts for 30 days after the last dose. Families should pick a workable combination with the prescriber before the 30-day clock starts.
What Changed in 2026?
According to Drugs.com reporting on the FDA action, FDA approved iPLEDGE changes on Feb. 9, 2026 for use starting Aug. 9, 2026 to reduce burden while keeping fetal-risk safeguards. Dermatology Advisor reporting on the FDA change says the agency dropped the CLIA-certified laboratory requirement.
Prescribers may now allow home tests during and after treatment. Starting treatment stays stricter. According to the FDA iPLEDGE website update, every test required before the first dose must be done in a medical setting such as a prescriber office, clinic, or laboratory. The Journal of Dermatology for NPs/PAs reporting on FDA notes one limit. Any repeat test before the first dose stays in a medical setting, and prescribers allowing home tests later must build steps to reduce falsification.
How Monthly Refills Stay on Track
After treatment starts, timing stays tight. According to a peer-reviewed cost study, the teen must complete monthly checks and pick up a 30-day supply within a 7-day window from the test collection date. A missed window means restarting the test-and-authorization process.
Parents can set phone reminders for test day and pharmacy day. Keep the lab slip and ask the office what date starts the seven days. Pick up early in the window to leave room for stock or authorization issues.
What to Ask at the Visit
Bring your teen's cycle dates and current birth-control use. Ask where both pretreatment tests will be done and how results reach the prescriber.
Confirm which two methods or abstinence choice will satisfy iPLEDGE for your family. Ask for written dates for the 30-day start, confirmatory test window, and earliest pickup day. Leave with a contact name for missed tests or cycle changes.
You Might Also Like
- Planned Home Pregnancy Testing Under the 2026 iPLEDGE Changes: Which Rules Apply Now for Parents of Teens With Severe Acne
- Pediatric Acne and Rosacea at the 2026 AAD Annual Meeting: Questions Parents of Teens With Acne Can Ask a Dermatologist
- Pediatric Acne and Rosacea at the 2026 AAD Annual Meeting: Diagnosis and Look-Alike Questions for Parents of Teens With Acne